Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Expression of SCCA serpin B3 as a marker of breast cancer progression

May 13, 2011

Hervix has long-term benefit on recurrence of bladder cancer

May 12, 2011

Talon Therapeutics to begin recruitment in phase III Marqibo trial

May 12, 2011

Duquesne University presents new tamoxifen-melatonin hybrid ligand

May 12, 2011

New anticancer agents prepared by Chinese scientists

May 12, 2011

Swissmedic approves Novartis' Votubia for brain tumors associated with tuberous sclerosis

May 11, 2011

Allos Therapeutics and Mundipharma to codevelop anticancer drug Folotyn

May 11, 2011

National Cancer Institute to sponsor phase I study of Reolysin in multiple myeloma

May 11, 2011

Roche seeks FDA and EMA approval for vemurafenib in metastatic melanoma

May 11, 2011

AstraZeneca discloses preclinical data on AZD-5363, in phase I testing in solid tumors

May 11, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.